BSE: 0 | NSE: | Chemicals |
BSE: 0 | NSE: | Chemicals |
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Recent Performance Summary not available for IPO
Recent Performance Summary not available for IPO
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | - | - |
| TTM Sales (₹ Cr.) | - | - |
| BVPS (₹.) ⓘ | - | - |
| Reserves (₹ Cr.) ⓘ | - | - |
| P/BV ⓘ | - | - |
| PE ⓘ | - | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | - / - |
| All Time Low / High (₹) | - / - |
| Market Cap (₹ Cr.) | - |
| Equity (₹ Cr.) | - |
| Face Value (₹) | - |
| Industry PE ⓘ | - |
| PARTICULARS | Mar'23 | Mar'24 |
|---|---|---|
| Sales | 7.46 | 10.16 |
| Operating Expenses ⓘ | 7.02 | 8.95 |
| Manufacturing Costs | 0.26 | 0.14 |
| Material Costs | 5.90 | 8.03 |
| Employee Cost | 0.49 | 0.47 |
| Other Costs ⓘ | 0.36 | 0.31 |
| Operating Profit ⓘ | 0.44 | 1.20 |
| Operating Profit Margin (%) | 5.9% | 11.8% |
| Other Income ⓘ | 0 | 0 |
| Interest ⓘ | 0.19 | 0.69 |
| Depreciation ⓘ | 0.01 | 0.02 |
| Exceptional Items ⓘ | 0 | 0 |
| Profit Before Tax ⓘ | 0.24 | 0.49 |
| Tax ⓘ | 0.07 | 0.15 |
| Profit After Tax | 0.17 | 0.34 |
| PAT Margin (%) | 2.3% | 3.4% |
| Adjusted EPS (₹) | 0.9 | 1.9 |
| Dividend Payout Ratio (%) | 0% | 0% |
| PARTICULARS | Mar'23 | Mar'24 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 0.68 | 1.03 | ||||||||
| Share Capital ⓘ | 0.05 | 0.05 | ||||||||
| Reserves ⓘ | 0.63 | 0.98 | ||||||||
| Minority Interest | 0 | 0 | ||||||||
| Debt | 2.77 | 4.86 | ||||||||
| Long Term Debt | 1.24 | 3.20 | ||||||||
| Short Term Debt | 1.53 | 1.66 | ||||||||
| Trade Payables | 1.56 | 0.55 | ||||||||
| Others Liabilities ⓘ | 0.11 | 1.49 | ||||||||
| Total Liabilities ⓘ | 5.12 | 7.93 | ||||||||
Fixed Assets | ||||||||||
| Gross Block | 0.05 | 0.06 | ||||||||
| Accumulated Depreciation | 0.02 | 0.03 | ||||||||
| Net Fixed Assets ⓘ | 0.03 | 0.02 | ||||||||
| CWIP ⓘ | 0 | 0 | ||||||||
| Investmentsⓘ | 0 | 0 | ||||||||
| Inventories | 0.59 | 2.60 | ||||||||
| Trade Receivables | 4.33 | 3.81 | ||||||||
| Cash Equivalents | 0.14 | 0.64 | ||||||||
| Others Assetsⓘ | 0.03 | 0.86 | ||||||||
| Total Assets ⓘ | 5.12 | 7.93 | ||||||||
| PARTICULARS | Mar'23 | Mar'24 |
|---|---|---|
| Cash Flow From Operating Activity ⓘ | -0.30 | -0.76 |
| PBT ⓘ | 0.24 | 0.49 |
| Adjustment ⓘ | 0.19 | 0.70 |
| Changes in Working Capital ⓘ | -0.66 | -1.89 |
| Tax Paid ⓘ | -0.06 | -0.07 |
| Cash Flow From Investing Activity ⓘ | -0.04 | -0 |
| Capex | -0.04 | -0 |
| Net Investments | -0 | 0 |
| Others ⓘ | 0 | 0 |
| Cash Flow From Financing Activityⓘ | 0.26 | 1.27 |
| Net Proceeds from Shares ⓘ | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0.43 | 1.96 |
| Interest Paid ⓘ | -0.18 | -0.69 |
| Dividend Paid ⓘ | 0 | 0 |
| Others ⓘ | 0 | 0 |
| Net Cash Flow ⓘ | -0.09 | 0.50 |
| PARTICULARS | Mar'23 | Mar'24 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 24.82 | 40.32 | ||||||||
| ROCE (%) | 12.44 | 22.41 | ||||||||
| Asset Turnover Ratio | 1.47 | 1.61 | ||||||||
| PAT to CFO Conversion(x) | -1.76 | -2.24 | Working Capital Days | |||||||
| Receivable Days | 210 | 141 | ||||||||
| Inventory Days | 29 | 55 | ||||||||
| Payable Days | 97 | 48 | ||||||||